Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,956Revenue $M2,046Net Margin (%)19.2Z-Score7.0
Enterprise Value $M8,850EPS $3.4Operating Margin %22.2F-Score4
P/E(ttm))31.0Cash Flow Per Share $2.6Pre-tax Margin (%)25.2Higher ROA y-yN
Price/Book6.810-y EBITDA Growth Rate %18.1Quick Ratio3.6Cash flow > EarningsY
Price/Sales4.65-y EBITDA Growth Rate %14.7Current Ratio4.5Lower Leverage y-yN
Price/Cash Flow34.9y-y EBITDA Growth Rate %-8.9ROA % (ttm)14.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)25.1Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M105ROI % (ttm)23.1Gross Margin Increase y-yN

Gurus Latest Trades with EW

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EWJoel Greenblatt 2014-03-31 Reduce-0.07%$64.17 - $73.93
($69.04)
$ 84.923%Reduce -39.12%71,689
EWVanguard Health Care Fund 2013-12-31 Add0.83%$61.44 - $78.14
($67.6)
$ 84.926%Add 306.07%5,324,000
EWJoel Greenblatt 2013-12-31 Add0.13%$61.44 - $78.14
($67.6)
$ 84.926%Add 278.76%117,760
EWRon Baron 2013-12-31 Reduce-0.21%$61.44 - $78.14
($67.6)
$ 84.926%Reduce -29.66%1,533,972
EWRay Dalio 2013-12-31 Sold Out -0.02%$61.44 - $78.14
($67.6)
$ 84.926%Sold Out0
EWRay Dalio 2013-09-30 Buy 0.02%$65.25 - $73.4
($70.25)
$ 84.921%New holding, 25695 sh.25,695
EWJoel Greenblatt 2013-09-30 Reduce-0.03%$65.25 - $73.4
($70.25)
$ 84.921%Reduce -26.19%31,091
EWRon Baron 2013-06-30 Add0.4%$62.54 - $84.93
($71.02)
$ 84.920%Add 135.69%1,985,766
EWMeridian Funds 2013-06-30 Add0.33%$62.54 - $84.93
($71.02)
$ 84.920%Add 33.69%506,700
EWVanguard Health Care Fund 2013-06-30 Buy 0.32%$62.54 - $84.93
($71.02)
$ 84.920%New holding, 1311100 sh.1,311,100
EWJoel Greenblatt 2013-06-30 Add0.1%$62.54 - $84.93
($71.02)
$ 84.920%Add 526.16%42,122
EWMeridian Funds 2013-03-31 Add0.11%$78.66 - $94.56
($88)
$ 84.9-4%Add 11.14%379,000
EWJoel Greenblatt 2013-03-31 Add0.01%$78.66 - $94.56
($88)
$ 84.9-4%Add 35.68%6,727
EWJoel Greenblatt 2012-12-31 Buy 0.03%$83.7 - $109.75
($89.78)
$ 84.9-5%New holding, 4958 sh.4,958
EWMeridian Funds 2012-12-31 Reduce-0.79%$83.7 - $109.75
($89.78)
$ 84.9-5%Reduce -37.67%341,000
EWRon Baron 2012-12-31 Reduce-0.15%$83.7 - $109.75
($89.78)
$ 84.9-5%Reduce -20.52%828,833
EWPRIMECAP Management 2012-09-30 Buy 0.05%$97.37 - $108.72
($102.24)
$ 84.9-17%New holding, 300000 sh.300,000
EWRichard Perry 2012-06-30 Sold Out -0.04%$68.5 - $102.97
($84.36)
$ 84.91%Sold Out0
EWPRIMECAP Management 2012-06-30 Sold Out -0.03%$68.5 - $102.97
($84.36)
$ 84.91%Sold Out0
EWMeridian Funds 2012-03-31 Add0.41%$68.43 - $82.67
($69.34)
$ 84.922%Add 52.76%564,749
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EW is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
EW PRIMECAP Management 2014-03-31280,0000.270.02
EW Vanguard Health Care Fund 2014-03-315,324,0005.051.1
EW Ron Baron 2014-03-311,354,5111.280.41-11.7%
EW Joel Greenblatt 2014-03-3171,6890.070.08-39.12%
EW Meridian Funds 2013-06-30506,7000.481.3+33.69%
Premium Most recent portfolio changes are included for Premium Members only!


EW: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
WANG HUIMINCVP, Japan & Intercontinental 2014-07-07Sell5,600$87.79-3.18view
BOBO DONALD E JRCVP, Heart Valve Therapy 2014-06-27Sell25,000$87-2.3view
MUSSALLEM MICHAEL AChairman & CEO 2014-06-24Sell29,500$85.38-0.45view
WANG HUIMINCVP, Japan & Intercontinental 2014-06-05Sell5,600$80.735.29view
MCNEIL BARBARA JDirector 2014-05-30Sell1,200$81.24.68view
MUSSALLEM MICHAEL AChairman & CEO 2014-05-28Sell29,500$79.337.15view
WANG HUIMINCVP, Japan & Intercontinental 2014-05-05Sell5,600$81.734view
Verguet Patrick BCVP, Europe 2014-05-05Sell10,000$83.042.36view
BOBO DONALD E JRCVP, Heart Valve Therapy 2014-04-14Sell25,000$823.66view
MUSSALLEM MICHAEL AChairman & CEO 2014-04-10Sell29,500$74.7113.77view

Press Releases about EW :

    Quarterly/Annual Reports about EW:

    News about EW:

    Articles On GuruFocus.com
    Weekly 3-Year Low Highlight: EW, NUAN, MNK, CROX, IRDM Nov 03 2013 
    Vanguard Health Care Fund Gains 27%, Buys 4 New Stocks Jul 31 2013 
    Ron Baron's Favorite Stocks Jun 28 2013 
    Ron Baron's Market Strategy - CNBC Interview Jun 28 2013 
    Guru Stocks at 52-Week Lows: EC, OKS, LFL, LINE, EW May 06 2013 
    Insider Buys at 52-Week Lows May 04 2013 
    Medical Technology Industry Reports Insider Sells at 52-Week Lows Apr 25 2013 
    Baron Funds Comments on Edwards Lifesciences Corp. Aug 07 2012 
    Weekly CFO Sells Highlight: OMC, NEE, EW, STZ, GRPN Aug 08 2012 
    WEEKLY CFO SELLS HIGHLIGHT: OMC, NEE, EW, STZ, GRPN Aug 06 2012 

    More From Other Websites
    EDWARDS LIFESCIENCES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jul 24 2014
    Edwards’ CEO Invited to Address Congress on Opportunities to Revitalize Medical Device Innovation Jul 22 2014
    Edwards' CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation Jul 22 2014
    Edwards Lifesciences To Host Earnings Conference Call on July 29, 2014 Jul 15 2014
    3 Stocks Pushing The Health Services Industry Downward Jul 14 2014
    Study Explores Expanded Use For Edwards' And Medtronic's New Heart Valves Jul 08 2014
    Edwards Lifesciences Monitor Gets FDA Nod Jul 02 2014
    Edwards Receives FDA Clearance For Advanced Noninvasive Monitoring System Jun 30 2014
    Edwards Lifesciences' Sapien XT Gains Approval, Competition Rife Jun 26 2014
    Company News for June 18, 2014 Jun 18 2014
    Edwards Lifesciences' Aortic Heart Valve Gets FDA Approval Jun 17 2014
    Edwards shares rise on new heart valve approval Jun 17 2014
    Edwards shares rise on new heart valve approval Jun 17 2014
    Edwards Lifesciences Rises After Sapien XT Approval Jun 17 2014
    Edwards shares jump after company wins approval for new heart valve Jun 17 2014
    Stocks to Watch: Edwards Lifesciences, Amira, Forest Oil Jun 17 2014
    Stock Futures Aim Firmly Lower; Amira Natural, Edwards Jump Jun 17 2014
    FDA Approves Second Generation Heart Valve From Edwards Lifesciences Jun 16 2014
    Edwards wins U.S. nod for next generation Sapien XT heart valve system Jun 16 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide